CP 8-9 Cash to monthly cash expenses ratio TearLab Corp. is a health care company that specializes in developing diagnostic devices for eye disease. TearLab reported the following data (in thousands) for three recent years: Real World FAI For Years Ended December 31 Year 3 Year 2 Year 1 $ 13,838 $ 16,338 $ 37,778 (23,703) (18,172) (13,234) Cash and cash equivalents Net cash flows from operations 1. Determine the monthly cash expenses for Year 3, Year 2, and Year 1. Round to one decimal place. 2. Determine the ratio of cash to monthly cash expenses as of December 31 for Year 3, Year 2, and Year 1. Round to one decimal place. 3. Based on (1) and (2), comment on TearLab's ratio of cash to monthly operating expenses for Year 3, Year 2, and Year 1